Transapical aortic valve implantation: predictors of survival up to 5 years in 730 patients. An update

European Journal of Cardio-thoracic Surgery

Volumn 47, Issue 2, 2015, Pages 281-290

  Unbehaun, Axel ^a   Pasic, Miralem ^a   Drews, Thorsten ^a   Penkalla, Adam ^a   Dreysse, Stephan ^a   Klein, Christoph ^a   Kukucka, Marian ^a   Mladenow, Alexander ^a   Hetzer, Roland ^a   Buz, Semih ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Aortic valve replacement; Aortic valve stenosis; Long term outcomes; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; CREATININE; PHENPROCOUMON; WARFARIN;

ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; AORTIC VALVE REPLACEMENT; AORTIC VALVE STENOSIS; ARTICLE; ATRIAL FIBRILLATION; CARDIOGENIC SHOCK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EUROSCORE; EVALUATION STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PREDICTOR VARIABLE; REOPERATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL PATIENT; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVE DETERIORATION; VERY ELDERLY; AORTA VALVE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MORTALITY; PROCEDURES; SURGERY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84928232831     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/EJCTS/EZU069     Document Type: Article

References (23)

1. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F et al. Percutaneous trans-catheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106: 3006–8.
2. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS et al. PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696–704.
3. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR et al. PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686–95.
4. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol 2012;60:1864–75.
5. Toggweiler S, Humphries KH, Lee M, Binder RK, Moss RR, Freeman M et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 2013;61:413–9.
6. Unbehaun A, Pasic M, Drews T, Dreysse S, Kukucka M, Hetzer R et al. Analysis of survival in 300 high-risk patients up to 2.5 years after transapical aortic valve implantation. Ann Thorac Surg 2011;92:1315–23.
7. Pasic M, Unbehaun A, Dreysse S, Drews T, Buz S, Kukucka M et al. Transapical aortic valve implantation in 175 consecutive patients: excellent outcome in very high-risk patients. J Am Coll Cardiol 2010;56:813–20.
8. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M et al. Introducing transapical aortic valve implantation (part 1): effect of a structured training program on clinical outcome in a series of 500 procedures. J Thorac Cardiovasc Surg 2013;145:911–8.
9. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M et al. Introducing transapical aortic valve implantation (part 2): institutional structured training program. J Thorac Cardiovasc Surg 2013;145:919–25.
10. Walther T, Dewey T, Borger MA, Kempfert J, Linke A, Becht R et al. Transapical aortic valve implantation: step by step. Ann Thorac Surg 2009; 87:276–83.
11. Pasic M, Dreysse S, Drews T, Buz S, Unbehaun A, Kukucka M et al. Improved technique of transapical aortic valve implantation: ‘the Berlin addition’. Ann Thorac Surg 2010;89:2058–60.
12. Pasic M, Unbehaun A, Dreysse S, Buz S, Drews T, Kukucka M et al. Rupture of the device landing zone during transcatheter aortic valve implantation: a life-threatening but treatable complication. Circ Cardiovasc Interv 2012; 5:424–32.
13. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438–54.
14. Statistisches Bundesamt. Periodensterbetafeln für Deutschland. Früheres Bundesgebiet, neue Länder sowie die Bundesländer. Wiesbaden: Statistisches Bundesamt, 2012;1–19.
15. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H et al. Guidelines on the management of valvular heart disease (version 2012). Eur J Cardiothorac Surg 2012;42: S1–44.
16. Brown JM, O’Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009;137: 82–90.
17. Thourani VH, Ailawadi G, Szeto WY, Dewey TM, Guyton RA, Mack MJ et al. Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg 2011;91:49–56.
18. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187–98.
19. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299–308.
20. Unbehaun A, Pasic M, Dreysse S, Drews T, Kukucka M, Mladenow A et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol 2012;59:211–21.
21. D’Ancona G, Pasic M, Buz S, Drews T, Dreysse S, Kukucka M et al. Transapical transcatheter aortic valve replacement in patients with cardiogenic shock. Interact CardioVasc Thorac Surg 2012;14:426–30.
22. Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 2006;15:49–56.
23. McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, Byrne JG et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 2010;89:1410–6.